RNAC

No price yet

Announcements

Nothing here yet

Daily updates

Nothing here yet

FDA designations

Nothing here yet

News

Cartesian Therapeutics reports additional retreatment data for Descartes-08 showing deep and durable responses in patients with myasthenia gravisSep 29, 2026
Cartesian Therapeutics announced strong efficacy signal in Phase 2 trial of Descartes-08 in SLE patients and expansion of clinical development into myositisNov 14, 2025
Cartesian Therapeutics enrolls first participant in Phase 3 AURORA trial of Descartes-08 for myasthenia gravisMay 30, 2025